default author photo

Nitin Jain

University of Texas at Houston - Department of Leukemia

SCHOLARLY PAPERS

4

DOWNLOADS

388

TOTAL CITATIONS

0

Scholarly Papers (4)

1.

Ponatinib and Blinatumomab for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Single-Arm, Phase 2 Trial

Number of pages: 28 Posted: 27 Apr 2022
University of Texas at Houston - Department of Leukemia, University of Texas at Houston - Department of Leukemia, University of Texas at Houston - Department of Leukemia, University of Texas at Houston - Department of Biostatistics, University of Texas at Houston - Department of Leukemia, The University of Texas MD Anderson Cancer Center - Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center - Department of Stem Cell Transplantation and Cellular Therapy, University of Texas at Houston - Department of Leukemia, University of Texas at Houston - Department of Leukemia, University of Texas at Houston - Department of Leukemia, University of Texas at Houston - Department of Leukemia, University of Texas at Houston - Department of Leukemia, University of Texas at Houston - Department of Leukemia, University of Texas at Houston - Department of Leukemia, University of Texas at Houston - Department of Leukemia, University of Texas at Houston - Department of Leukemia, University of Texas at Houston - Department of Leukemia, University of Texas at Houston - Department of Leukemia, University of Texas at Houston - Department of Leukemia, University of Texas at Houston - Department of Leukemia, University of Texas at Houston - Department of Leukemia and University of Texas at Houston - Department of Leukemia
Downloads 225 (343,660)

Abstract:

Loading...

blinatumomab, ponatinib, Philadelphia Chromosome, bcr-abl1, ALL

2.

Results of Salvage Therapy with Mini-Hyper-CVD and Inotuzumab Ozogamicin with or Without Blinatumomab in Pre-B Acute Lymphoblastic Leukemia

Number of pages: 45 Posted: 06 Dec 2022
University of Texas at Houston - Department of Leukemia, University of Texas at Houston - Department of Leukemia, University of Texas at Houston - Department of Leukemia, University of Texas at Houston - Department of Leukemia, University of Texas at Houston - Department of Leukemia, University of Texas at Houston - Department of Hematopathology, University of Texas at Houston - Department of Hematopathology, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - Department of Leukemia, University of Texas at Houston - Department of Leukemia, University of Texas at Houston - Department of Pharmacy, University of Texas at Houston - Department of Leukemia, University of Texas at Houston - Department of Radiation Oncology, University of Texas at Houston - Department of Leukemia, University of Texas at Houston - Department of Leukemia, University of Texas at Houston - Department of Leukemia, University of California, Irvine - Chao Family Comprehensive Cancer Center, University of Texas at Houston - Department of Leukemia and University of Texas at Houston - Department of Leukemia
Downloads 73 (860,052)

Abstract:

Loading...

Philadelphia-negative ALL, inotuzumab, blinatumomab, chemo-immunotherapy, salvage, outcome

3.

Acute Leukemia with BCL11B Rearrangements: Genetic Landscape, BCL11B Expression, and Therapeutic Response

Number of pages: 22 Posted: 27 Dec 2025
University of Texas at Houston - Department of Hematopathology, University of Texas at Houston - MD Anderson Cancer Center, affiliation not provided to SSRN, University of Texas at Houston - Department of Hematopathology, University of Texas at Houston - Department of Hematopathology, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Texas at Houston - Department of Leukemia, University of Texas at Houston - Department of Leukemia, affiliation not provided to SSRN and University of Texas at Houston - Department of Hematopathology
Downloads 66 (961,006)

Abstract:

Loading...

BCL11B-rearrangement, BCL11B expression, T-ALL, MPAL T/M phenotype, optical genome mapping, partner genes

4.

Treatment in Clinical Trials Could Mitigate Socioeconomic and Racial Disparities in Acute Myeloid Leukemia

Number of pages: 37 Posted: 27 Apr 2026
University of Texas at Houston - Department of Leukemia, University of Texas at Houston - MD Anderson Cancer Center, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Texas at Houston - Department of Leukemia, University of Texas at Houston - Department of Leukemia, affiliation not provided to SSRN, University of Texas at Houston - Department of Leukemia, University of Texas at Houston - Department of Leukemia, affiliation not provided to SSRN, University of Texas at Houston - Department of Leukemia, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - Department of Leukemia, University of Texas at Houston - Department of Leukemia, affiliation not provided to SSRN, University of Texas at Houston - Department of Leukemia, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Texas at Houston - Department of Biostatistics, affiliation not provided to SSRN, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - Department of Stem Cell Transplantation and Cellular Therapy, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - Department of Leukemia and University of Texas at Houston - Department of Leukemia
Downloads 24 (1,411,822)

Abstract:

Loading...

Area deprivation index, racial/ethnic disparity, clinical trials, stem cell transplant